Green Thumb Industries (GTBIF) Net Cash Flow Growth (1y) (2020 - 2026)
Green Thumb Industries (GTBIF) Net Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -1,020.00% |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 56.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.65% |
| Dec 31, 2025 | 2,652.15% |
| Sep 30, 2025 | 359.94% |
| Jun 30, 2025 | -21.10% |
| Mar 31, 2025 | -37.57% |
| Dec 31, 2024 | -107.88% |
| Sep 30, 2024 | -84.68% |
| Jun 30, 2024 | 23.52% |
| Mar 31, 2024 | 710.71% |
| Dec 31, 2023 | -18.51% |
| Sep 30, 2023 | -715.04% |
| Jun 30, 2023 | -24.19% |
| Mar 31, 2023 | 113.75% |
| Dec 31, 2022 | 154.94% |
| Sep 30, 2022 | 102.70% |
| Jun 30, 2022 | -135.13% |
| Mar 31, 2022 | -129.08% |
| Dec 31, 2021 | -1,077.05% |
| Sep 30, 2021 | -1,412.84% |
| Jun 30, 2021 | 629.29% |